Illustration of colorful blocks resembling tetriminoes

“Tetris for Trauma” Viral Twitter Thread: A Master Class in Misleading Psych Research

11
A TV writer claims that research shows that Tetris is “literally a trauma first aid kit.” Her tweets sound scientific, but the research behind it is unconvincing.

Psychiatry, Fraud, and the Case for a Class-Action Lawsuit

202
For decades, psychiatry committed medical fraud when it told the public that antidepressants fixed a chemical imbalance in the brain.

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

22
MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.

Overuse of Psychiatric Drugs is Worsening Public Mental Health, Doctor Argues

12
A new research article asserts that the overuse of psychiatric drugs may create neurobiological changes that hamper long-term mental health recovery.
Photograph of two faces in psychedelic colors with dark background

Ending The Silence Around Psychedelic Therapy Abuse

78
All the new hype about miracle psychedelic treatments as the next wave of cures for mental disorders leaves out the risk of therapy abuse.

The WHO and the United Nations: Let Freedom Ring for the Mad

23
This is a call that challenges how psychiatry is practiced today and ultimately challenges its power in society.
Illustration of man sitting on a red and white pill. He holds his head with pain symbols in the air above him.

Adding Antipsychotics Worsens Outcomes in Psychotic Depression

14
Outcomes were worse for all, with young people on combination therapy twice as likely to experience rehospitalization or death by suicide than those on antidepressants alone.

The STAR*D Scandal: Scientific Misconduct on a Grand Scale

36
The American Journal of Psychiatry Needs to Retract Study That Reported Fraudulent Results

Medication Overload, Part II: The Explosion of Drugs for Kids

17
An analysis of the huge increase in drugs for children, the role of Big Pharma, and a look at the impact on families and communities.

Psychiatric Drugs Increase Dementia Risk Threefold After COVID in 65+ Population

14
Hospitalized COVID patients over 65 were three times as likely to receive a dementia diagnosis if they took psychiatric drugs.
Illustration of a man standing on a rock surrounded by ocean waves

Thomas Szasz Versus the Mental Health Movement

102
Unbiased experts must examine the claims and research of psychiatry and issue a report as to whether psychiatry not only has a valid medical basis, but whether this basis justifies the widespread violation of medical ethics and the routine use of imprisonment and torture.

Words from My Heart to ‘My Heart’: What Might Have Helped My Late Friend?

5
More than two and a half years later, I’m still processing my grief, still picturing our happiness and innocence as kids, and still acknowledging our struggles and pain.

Mad in America’s 10 Most Popular Articles in 2023

13
A roundup of Mad in America's most read blogs and personal stories of 2023 as chosen by our readers.

ADHD Diagnosis Leads to Worse Quality of Life, Increased Self-Harm in Kids

38
When comparing kids with the same symptoms who were either diagnosed with ADHD or not, those who received the diagnosis had worse outcomes.

Q&A: How Can We See ADHD From Another Angle, and What Can We Do...

18
We all want to help our kids or our students, and sometimes finding the right key to unlock a child’s gifts is a matter of time, patience, trial, and error.

David Healy – Polluting Our Internal Environments: The Perils of Polypharmacy

154
On the MIA Podcast, Dr David Healy discusses World Tapering Day, antidepressant treatment and sensory neuropathy and the difficulties that can be encountered when trying to deprescribe.

State Hospital Memories: More of My Story

23
The Detroit Free Press did an excellent job in bringing to light the conditions at Pontiac, its loss of accreditation, and closing. Still, they didn't quite grasp the severity of violence there.
Richard "Dick" Schwartz alongside the cover of his book, "No Bad Parts"

The Parts Within Us: An Interview with Richard Schwartz, Creator of Internal Family Systems

20
IFS is a different paradigm, which says that rather than being a sign of pathology, it’s the nature of the mind to have “parts." We’re born that way because they're all valuable.

Books Under Review: Fall 2021

2
Reviews of four recent books reflecting various perspectives on the mental health system, including explorations of the DSM and Open Dialogue.
A collage depicting cut-up photographs of David Carmichael and his son Ian, Lindsay Clancy and her children, and a bottle of pills spilling out

SSRIs, Lindsay Clancy, and Me

16
Sharing the similarities between Lindsay Clancy's homicidal episode and my own will hopefully help prevent rare SSRI-induced suicides and homicides, including mass shootings.
Close-up of a gold padlock hanging from a man's belt

Antidepressants Have Destroyed My Sexual Function and Range of Emotions

32
In 2012, in a period of low mood and anxiety, my GP prescribed an antidepressant. Little did I know that this would derail my life.

Teen Arts Exhibition: Beyond Labels And Meds: What It Feels Like To Be Me

6
28 teen artists share the power of their creativity in this collection of profoundly moving, courageous, and beautiful artwork.

Waking From the Nightmare: Is Recovery From Akathisia Possible?

53
I had a chemical brain injury from medications. The only help doctors could offer was more medications: treating the failed treatment with other dangerous treatments.

Catherine’s Story: A Child Lost to Psychiatry 

144
A year ago today, our youngest child died, thanks to the adversarial actions and toxic treatments foisted on her by medical-model psychiatry. By telling her story, we hope to promote systemic change.

Anatomy of an Industry: Commerce, Payments to Psychiatrists and Betrayal of the Public Good

69
Pharmaceutical companies paid psychiatrists $340 million from 2014 through 2020, corrupting every aspect of the testing and marketing of new psychiatric drugs.